Beryl Drugs Ltd
₹0.00▲ +0.00 (+0.00%)
524606·NSE·Healthcare
Market Cap
11.10 Cr
PE Ratio
26.10
Volume
—
Day High - Low
—
52W High-Low
30.00 - 15.92
₹0.00▲ +0.00 (+0.00%)
Market Cap11.10 Cr
PE Ratio26.10
Volume—
Day High - Low—
52W High-Low30.00 - 15.92
Beryl Drugs Ltd (524606): company summary
Beryl Drugs Ltd (524606) is a micro-cap Healthcare company valued at ₹11 crore operating in Pharmaceuticals on the NSE and BSE.
Beryl Drugs Ltd (524606) is a micro-cap Healthcare company valued at ₹11 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -11.2% a year over three years; profit fell 14.6% a year, behind revenue — margins are under pressure. Return on equity is 4.3%.
- Valuation multiples
- The stock trades at 26.1 times earnings, a discount to the Healthcare median of 32.5, 1.13 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
4.33%
Weak
P/E
26.10x
Fair
Debt / Equity
0.25
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak
Price performance
52W₹15.92
₹30.00
DocStoX take
Supported by growth (6.3), but held back by quality (3.6). Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.5
/10
Weak
Quality
Modest
ROE 4.3%
Valuation
Rich
P/E 26.1×
Growth
Steady
Revenue +6.0% 5Y CAGR
Risk
Elevated
D/E 0.25
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹11 Cr
52W High / Low
₹30 / ₹16
Dividend Yield
0.00%
Promoter Holding
27.82%
EPS (TTM)
₹1.14
Book Value
₹19.44
Key highlights
- Small ₹11 cr company — thinner liquidity
0 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Beryl Drugs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Beryl Drugs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Beryl Drugs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing